| PERIOD ENDING | 10-Aug-09 | 18-May-09 | 26-Jan-09 | 3-Nov-08 | | Total Revenue | 335,967 | 446,804 | 327,454 | 336,595 | | Cost of Revenue | 266,369 | 354,201 | 264,956 | 271,337 | | | Gross Profit | 69,598 | 92,603 | 62,498 | 65,258 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 45,976 | 61,880 | 47,275 | 46,261 | | Non Recurring | 1,359 | 916 | 1,473 | 1,497 | | Others | 95 | 132 |
-
| (255) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,168 | 29,675 | 13,750 | 17,755 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 425 | 862 | 788 | 769 | | Earnings Before Interest And Taxes | 22,593 | 30,537 | 14,538 | 18,524 | | Interest Expense | 2,060 | 6,344 | 12,279 | 9,363 | | Income Before Tax | 20,533 | 24,193 | 2,259 | 9,161 | | Income Tax Expense | 8,283 | 9,798 | (349) | 3,773 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,250 | 14,395 | 2,608 | 5,388 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,250 | 14,395 | 2,608 | 5,388 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,250 | $14,395 | $2,608 | $5,388 |
|
0.29% Nasdaq 
Income Statement
